Navigation Links
GW researcher receives more than $1 million in grants to study epigenetics of pancreatic cancer

WASHINGTON (July 1, 2014) Alexandros Tzatsos, M.D., Ph.D., assistant professor of anatomy and regenerative biology at the George Washington University School of Medicine and Health Sciences, was awarded over one million dollars in grants from the National Institutes of Health to study the molecular foundations of pancreatic cancer.

In May, Tzatsos received an R00 award for $706K, which is the second phase of a National Cancer Institute K99/R00 Howard Temin Pathway to Independence Award in Cancer Research a grant meant to aid young researchers in setting up independent research labs. This grant will fund his research project, "The Role of Epigenetic Regulators in Pancreatic Cancer." In February, Tzatsos also received a $374K R21 award to fund his research project, "Elucidating and Targeting Epigenetic Oncogenic Networks in Pancreatic Cancer."

According to the American Cancer Society, pancreatic cancer is the fourth leading cause of cancer-related death in the U.S. Few cases are found early enough for effective treatment. Tzatsos studies the role of a histone demethylase that drives the development of pancreatic cancer and he has generated new genetically engineered mouse models to address the role of this epigenetic regulator in vivo.

"We propose to use those mouse models to study pancreatic cancer and develop targeted therapies in a preclinical level," said Tzatsos. "This could be key to understand the molecular pathology of pancreatic cancer and develop better therapies."


Contact: Lisa Anderson
George Washington University

Page: 1

Related medicine news :

1. Mayo Clinic researchers reveal treasure trove of genes key to kidney cancer
2. Researchers seek to tackle transplant tolerance using patients own T cells
3. Moffitt researchers develop new way to combat drug resistance for melanoma patients
4. Researchers estimate 5.8 million A&E visits occur after patients unable to see a GP
5. Researchers conduct comprehensive review of treatments for depression in cancer patients
6. Miriam Hospital researchers develop app focused on making obese adults less sedentary
7. Researchers home in on way to predict aggressiveness of oral cancer
8. Researchers call for patients who receive home nutritional care to have emergency plans
9. Chronic brain damage not as prevalent in NFL players, say researchers
10. Researchers treat incarceration as a disease epidemic, discover small changes help
11. Researchers publish one of the longest longitudinal studies of cognition in MS
Post Your Comments:
(Date:11/28/2015)... PITTSBURGH, PA (PRWEB) , ... November 28, 2015 , ... ... Manalapan, N.J., has created the COUCH BUDDY. "I conceived of this design due to ... more comfort for couch users. It promotes relaxation and convenience, as well as increases ...
(Date:11/27/2015)... Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... conversation at the recent 2015 American Dental Association meeting in Washington D.C. revolved around ... help protect a patient’s overall health. The talk stressed the link between periodontal disease ...
(Date:11/27/2015)... Raleigh, NC (PRWEB) , ... November 27, 2015 , ... ... most effective ways to treat it. Surviving Mesothelioma has just posted the findings ... Researchers at University Hospital Zurich analyzed the cases of 136 mesothelioma patients who were ...
(Date:11/27/2015)... ... November 27, 2015 , ... The print component of ... in Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation of approximately ... nationally, through a vast social media strategy and across a network of top ...
(Date:11/27/2015)... ... November 27, 2015 , ... Intellitec ... Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group for end users ... Dynamics SL software users, partners, industry experts and representatives. Intellitec Solutions’ membership status ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... ) ... "2016 Global Tumor Marker Testing Market: Supplier ... Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive ... offering. --> ) has ... Global Tumor Marker Testing Market: Supplier Shares ...
(Date:11/26/2015)... --> --> ... immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer.   ... with Bremachlorin-photodynamic therapy for advanced cancer.   ... with Bremachlorin-photodynamic therapy for advanced cancer.   ... immunotherapy can be efficiently combined with photodynamic therapy (PDT) ...
(Date:11/26/2015)... , November 26, 2015 3D ... by 2022, according to a new report by Grand View ... Kidney Disease (CKD) which demands kidney transplantation is expected to ... cost effective substitute for organ transplantation. --> 3D ... by 2022, according to a new report by Grand View ...
Breaking Medicine Technology: